Manufacturer record
Venus Bio Sciences Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Venus Bio Sciences Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2020 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Venus Bio Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Injection I.P. 75 mg/2ml | VB/LEF0789Mfg 2025-07 · Exp 2027-06 | The sample does not conform to I.P. with respect to the tests of Identification and Assay of Diclofenac Sodium. The sample gives positive test for Identification of Buprenorphine. The sample is deemed to be spurious vide section 17 B of Drugs and Cosmetics Act 1940 and Rule 1945.Assay | CDL, KolkataCDSCO lab | Apr 2026 |
| Diclofenac Sodium Injection I.P. 75 mg/2ml. | VB/LEF0789Mfg 2025-07 · Exp 2027-06 | The sample does not conform to I.P. with respect to the tests of Identification and Assay of Diclofenac Sodium.Assay | CDL, KolkataCDSCO lab | Mar 2026 |
| BETAMETHASONE SODIUM PHOSPHATE TABLETS IP 0.5 mg (BETNECON) | VNT-19L17Mfg 2019-12 · Exp 2021-11 | AssayAssay | RDTL GuwahatiState lab | Aug 2021 |
| MOXEL-250 (Amoxycillin Capsules IP 250 mg) | VBC-19I25Mfg 2019-09 · Exp 2022-08 | AssayAssay | CDTL MumbaiCDSCO lab | Mar 2021 |
| Ranius ? 300 (Ranitidine Tablets I.P. 300 mg) | VNT?19A02Mfg 2019-01 · Exp 2020-12 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Sep 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.